Situation: A 45-year-old man with epilepsy is brought to the emergency department having a generalized tonic-clonic seizure. He weighs 60 kg. His family says he ran out of his antiseizure medication four days ago and drinks alcohol heavily. During the fosphenytoin loading infusion, the seizure stops. His blood pressure falls from 132/80 to 84/50 mmHg, and the cardiac monitor shows a heart rate of 50 beats/min, down from 104. What should the nurse do FIRST?

Hypotension and bradycardia are the main cardiovascular risks of intravenous fosphenytoin and phenytoin, and they are related to the infusion rate. The nurse slows or stops the infusion and notifies the provider while monitoring the rhythm and blood pressure.

Clinical situation

A 45-year-old man with epilepsy arrives in status epilepticus after running out of his antiseizure medication and drinking heavily. During a fosphenytoin loading infusion, his seizure stops, but his blood pressure drops to 84/50 mmHg and his heart rate falls to 50 beats/min. The priority nursing action is to slow or stop the fosphenytoin infusion and notify the provider immediately.

Why hypotension and bradycardia occur

Fosphenytoin is a water-soluble prodrug that is rapidly converted to phenytoin after intravenous administration. Although fosphenytoin was developed to reduce infusion-site pain and cardiovascular complications compared with intravenous phenytoin, it still carries a dose- and rate-dependent risk of hypotension and bradycardia ^[1]. The cardiovascular depressant effects are primarily related to the active metabolite, phenytoin, which can suppress cardiac conduction and reduce peripheral vascular tone when high plasma concentrations are achieved rapidly.

In this patient, the blood pressure fell from 132/80 mmHg to 84/50 mmHg, and the heart rate dropped from 104 beats/min to 50 beats/min. This combination of hypotension and bradycardia during the infusion strongly suggests a rate-related cardiovascular adverse reaction rather than a simple vasovagal response or dehydration. The seizure stopping does not mean the infusion is safe to continue at the same rate.

Why slowing or stopping the infusion is the first action

The primary nursing intervention for infusion-related cardiovascular depression is to reduce the rate of drug delivery. Fosphenytoin is typically infused at a maximum rate of 150 mg phenytoin equivalents (PE)/min in adults, but older patients, those with preexisting cardiac disease, or those who are hemodynamically unstable may require slower rates . When hypotension or bradycardia develops, the infusion should be slowed or temporarily stopped to allow the blood pressure and heart rate to recover.

Watch out! Continuing the infusion at the same rate can worsen hypotension and progress to cardiovascular collapse. Giving a fluid bolus while the infusion continues does not address the underlying cause, which is the rate of drug administration. Switching to intravenous phenytoin is not appropriate because phenytoin itself has similar or greater cardiovascular depressant effects when infused rapidly ^[1].

Comparison of fosphenytoin and phenytoin cardiovascular risks

Characteristic	Fosphenytoin	Phenytoin
Infusion rate	Faster (up to 150 mg PE/min)	Slower (up to 50 mg/min)
Infusion-site pain	Less	More (due to propylene glycol vehicle)
Hypotension risk	Present, rate-related	Present, rate-related
Bradycardia risk	Present, rate-related	Present, rate-related
First action if hypotension occurs	Slow or stop infusion	Slow or stop infusion

Clinical monitoring during fosphenytoin infusion

Continuous cardiac monitoring and frequent blood pressure measurement are essential during the loading dose. The nurse should observe for progressive bradycardia, hypotension, widening of the QRS complex, or new arrhythmias. If the blood pressure falls below 90 mmHg systolic or the heart rate drops below 60 beats/min during the infusion, the infusion should be slowed or stopped and the provider notified ^[1].

Key point! The seizure stopping is a therapeutic effect, but it does not protect the patient from cardiovascular adverse effects. The priority is to manage the hemodynamic instability caused by the infusion rate.

Special considerations in this patient

This patient has additional risk factors that may increase his vulnerability to cardiovascular depression. Heavy alcohol use can cause electrolyte imbalances, dehydration, and altered cardiac conduction. He has been without his antiseizure medication for four days, which means his baseline neurological status is unstable. These factors do not change the first nursing action, but they reinforce the need for careful hemodynamic monitoring during and after the infusion ^[1].

The correct first action is to slow or stop the fosphenytoin infusion and notify the provider while continuing to monitor cardiac rhythm and blood pressure.